Gillard S E, Finlay A Y
Abacus International, Bicester, Oxon, UK.
Int J Clin Pract. 2005 Nov;59(11):1260-7. doi: 10.1111/j.1368-5031.2005.00680.x.
The current management of psoriasis and its associated resource use in the United Kingdom (UK) was investigated in this retrospective analysis of 789,300 primary care patient records. Most patients with psoriasis (94%) were managed on topical psoriasis agents only, 4% were prescribed systemic psoriasis agents and 2% had no recorded psoriasis treatment at all during the 12-month study period. Co-medications to treat physical or psychological comorbidities were required by 22% of patients. Referral rates into secondary care were low, 5% of patients prescribed systemic psoriasis agents and 0.7% of patients prescribed topical psoriasis agents had secondary care appointments documented in their medical records. This study demonstrates that most patients with psoriasis in UK primary care are managed on topical agents even though there are surrogate markers, such as resource use and co-medication prescriptions, which indicate that their psoriasis is not optimally controlled.
在这项对789300份初级保健患者记录的回顾性分析中，对英国目前银屑病的管理及其相关资源使用情况进行了调查。在为期12个月的研究期间，大多数银屑病患者（94%）仅接受局部银屑病药物治疗，4%的患者被开具了全身性银屑病药物，2%的患者在记录中根本没有接受银屑病治疗。22%的患者需要使用治疗身体或心理合并症的联合用药。二级护理转诊率较低，在开具全身性银屑病药物的患者中，5%的患者和开具局部银屑病药物的患者中，0.7%的患者在其病历中有二级护理预约记录。这项研究表明，英国初级保健中的大多数银屑病患者接受局部药物治疗，尽管有替代指标，如资源使用和联合用药处方，表明他们的银屑病没有得到最佳控制。
Zotero 插件